Eltrombopag, sold under the brand name Promacta among others, is a medication used to treat thrombocytopenia (abnormally low platelet counts) and severe aplastic anemia. Eltrombopag is sold under the brand name Revolade outside the US and is marketed by Novartis. It is a thrombopoietin receptor agonist. It is taken by mouth.
via Wikipedia infobox
{{Infobox drug | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 461093150 | image = eltrombopag.svg | image_class = skin-invert-image | width = 270 | alt = | caption =
| pronounce = | tradename = Promacta, Revolade, others | Drugs.com = | MedlinePlus = a609011 | DailyMedID = Eltrombopag olamine | pregnancy_AU = B3 | pregnancy_AU_comment = | pregnancy_category = | routes_of_administration = By mouth | class = | ATC_prefix = B02 | ATC_suffix = BX05 | ATC_supplemental =
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).